跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 117,909 条关于
“rare kidney disease”
全部
117,909
临床试验
92,542
药物
1,544
机构
514
资讯
23,309
8个月前
Akebia Therapeutics Initiates Phase 2 Trial of Praliciguat for Rare Kidney Disease FSGS
去年
Advicenne Submits FDA Registration Application for Sibnayal® in Rare Kidney Disease Treatment
9个月前
Akebia Therapeutics Establishes Rare Kidney Disease Pipeline with Two Novel Therapeutic Candidates
2年前
Travere Therapeutics' Filspari Nears, But Misses, Primary Endpoint in IgA Nephropathy Trial
7个月前
Novartis Reports Positive Phase III Results for Fabhalta in Rare Kidney Disease C3 Glomerulopathy
去年
Apellis Secures $300 Million in Non-Dilutive Financing Through Sobi Royalty Agreement for Rare Kidney Disease Therapy
9个月前
Dimerix Completes Recruitment for Phase 3 Trial of DMX-200 in Rare Kidney Disease FSGS
去年
FDA Approves Tremfya for Crohn's Disease and Fabhalta for Rare Kidney Disease Amid Major Pharma Acquisitions
11个月前
Dimerix's DMX-200 Receives Orphan Drug Designation in Japan for Rare Kidney Disease Treatment
去年
Walden Biosciences Engages Former FDA Director to Advance WAL0921 Phase 2 Trial in Rare Kidney Diseases
第 1 页,共 2331 页
上一页
下一页